Sertoli-Leydig Cell Tumor from Latifa Hospital, Dubai UAE: Case Report  

作　　者：Z. Almahloul A. B. Fazari L. Paulose Z. Nagshabandi T. Gergawi 

机构地区：[1]Latifa Hospital Dubai Health Authority, Dubai, UAE

出　　处：《Open Journal of Obstetrics and Gynecology》2020年第2期319-325,共7页妇产科期刊（英文）

摘　　要：Sertoli-Leydig cell tumors (SLCTs) are rare tumors. Mass and pain are the presenting feature. The varying histopathology and differentiation of this tumor present difficulties with proper diagnosis and development of optimal treatment regimens. The prognosis depends on tumors grading and staging. Surgery is main stay management option. Chemotherapy and radiation options are still of choice.?We aimed?to?present Sertoli-Leydig cell tumor managed surgical at Latifa Hospital in Dubai, UAE with acceptable outcome and good patient satisfaction.Sertoli-Leydig cell tumors (SLCTs) are rare tumors. Mass and pain are the presenting feature. The varying histopathology and differentiation of this tumor present difficulties with proper diagnosis and development of optimal treatment regimens. The prognosis depends on tumors grading and staging. Surgery is main stay management option. Chemotherapy and radiation options are still of choice.?We aimed?to?present Sertoli-Leydig cell tumor managed surgical at Latifa Hospital in Dubai, UAE with acceptable outcome and good patient satisfaction.

关 键 词：Ovarian TUMORS Sertoli-Leydig Cell TUMORS Clitoromegaly VIRILIZATION 

分 类 号：R73[医药卫生—肿瘤]